🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Moderate to Severe Refractory Autoimmune Diseases

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases NCT07333118EARLY Phase 11 site📍 Shanghai Grit Biotechnology · Tests: GT801 Injection A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis NCT07570862Phase 212 sites📍 Beverly Hills📍 Fontana📍 Fullerton Fate Therapeutics · Tests: FT819 Alnuctamab for Refractory SLE (LATTE Study) NCT07219563Phase 11 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Alnuctamab Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease NCT07547930Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Tofacitinib GT719 Injection for Moderate to Severe Refractory Autoimmune Disease NCT07132112EARLY Phase 11 site📍 Nantong Grit Biotechnology · Tests: GT719 Injection CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris NCT07681388NA1 site📍 Wuhan Jinbo Chen · Tests: Autologous CD19 CAR-T cells Treatment of Moderate to Severe Refractory Crohn's Disease NCT06721962Phase 1, Phase 213 sites📍 Scottsdale📍 Sacramento📍 San Francisco Tr1X, Inc. · Tests: TRX103, Cyclophosphamide CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus NCT06349343Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: CD19/BCMA CAR-T cell therapy The Clinical Study on the Treatment of Refractory RA With UTAA91 Injection NCT07001956EARLY Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: UTAA91 injection GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases NCT07122076EARLY Phase 11 site📍 Shanghai Grit Biotechnology · Tests: GT719 Injection Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE NCT07031713Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: CAR-T Therapy Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) NCT07513181Phase 24 sites📍 Miami📍 Tampa📍 Roswell Athos Therapeutics Inc · Tests: ATH-063, Placebo An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus NCT06010472EARLY Phase 11 site📍 Shanghai Changhai Hospital · Tests: anti-CD19 CAR NK cells (KN5501) A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate to Severe Refractory Autoimmune Diseases NCT07614191EARLY Phase 11 site📍 Shanghai Vivacta Biotechnology (Shanghai) Co., Ltd. · Tests: GT801 Injection A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus NCT07339332EARLY Phase 11 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: CAR-T Therapy MTS109 in Patients With Refractory Autoimmune Diseases NCT07526350EARLY Phase 11 site📍 Shanghai Shanghai Changzheng Hospital · Tests: MTS109 CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc) NCT06822881Phase 11 site📍 Beijing Beijing GoBroad Hospital · Tests: CAR-T Therapy The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis NCT07017686NA3 sites📍 Fitzroy📍 Fitzroy📍 Ivanhoe The Bionics Institute of Australia · Tests: abdominal vagus nerve stimulation (aVNS)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy